Breaking Rory McIlroy Shares Lead at BMW Championship Amid Scottie Scheffler’s Struggles Hong Kong Court to Rule on National Security Charges for Tiananmen Commemoration Organizers Woman Arrested, Accused of Plotting ISIS-Inspired Attack on New York State Capitol Harvard Medical School Agrees to $53 Million Settlement in Body Donor Mishandling Lawsuits Northwest Indiana Residents Endure Ninth Day Without Power After Deadly Storm; Central Ohio Faces Flash Flooding

Thursday August 20, 2026

Reporter

Creative Medical Technology Holdings, Inc.

2Articles Published

4Communities Covered

Published Articles

Press Release

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning

12 hours ago

Press Release

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms

Aug 6